5-ALA induced PpIX fluorescence spectroscopy in neurosurgery: a review.

"Conflict of interest PV is a consultant for an unrelated imaging study for NX Development Corp and has multiple patents or provisional patents on fluorescence imaging technologies for fluorescence-guided neurosurgery. PV and JB have equity in Lumiere Optix. JB has an equity position in Treovir Inc. and UpFront Diagnostics. JB is also on the Centile Bioscience, QV Bioelectronics, and NeuroX1 boards of scientific advisors. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision."

"The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work has been funded in part by a public grant from the French National Research Agency (ANR) under the “France 2030” investment plan, which has the reference EUR MANUTECH SLEIGHT—ANR-17-EURE-0026 (BM); in part by the Université de Lyon through program LABEX PRIMES under Grant ANR-11-LABX-0063 within the program Investissements d’Avenir under Grant ANR-11-IDEX-0007, operated by the French National Research Agency (BM); in part by France Life Imaging under Grant ANR-11-INBS-0006 within the program Infrastructures d’Avenir en Biologie Santé, operated by the French National Research Agency (BM); and in part by a Cancer Prevention Research Institute of Texas Early Clinical Investigator grant # RP220581 (PV) and National Institutes of Health Trailblazer grant # 5R21EB034033 (PV)."